rs3024480

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBS1BS2

The NM_000129.4(F13A1):​c.1112+17A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00827 in 1,612,940 control chromosomes in the GnomAD database, including 114 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.013 ( 33 hom., cov: 32)
Exomes 𝑓: 0.0077 ( 81 hom. )

Consequence

F13A1
NM_000129.4 intron

Scores

2

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: 0.549

Publications

2 publications found
Variant links:
Genes affected
F13A1 (HGNC:3531): (coagulation factor XIII A chain) This gene encodes the coagulation factor XIII A subunit. Coagulation factor XIII is the last zymogen to become activated in the blood coagulation cascade. Plasma factor XIII is a heterotetramer composed of 2 A subunits and 2 B subunits. The A subunits have catalytic function, and the B subunits do not have enzymatic activity and may serve as plasma carrier molecules. Platelet factor XIII is comprised only of 2 A subunits, which are identical to those of plasma origin. Upon cleavage of the activation peptide by thrombin and in the presence of calcium ion, the plasma factor XIII dissociates its B subunits and yields the same active enzyme, factor XIIIa, as platelet factor XIII. This enzyme acts as a transglutaminase to catalyze the formation of gamma-glutamyl-epsilon-lysine crosslinking between fibrin molecules, thus stabilizing the fibrin clot. It also crosslinks alpha-2-plasmin inhibitor, or fibronectin, to the alpha chains of fibrin. Factor XIII deficiency is classified into two categories: type I deficiency, characterized by the lack of both the A and B subunits; and type II deficiency, characterized by the lack of the A subunit alone. These defects can result in a lifelong bleeding tendency, defective wound healing, and habitual abortion. [provided by RefSeq, Jul 2008]
F13A1 Gene-Disease associations (from GenCC):
  • factor XIII, A subunit, deficiency of
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine, ClinGen
  • congenital factor XIII deficiency
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BP6
Variant 6-6222016-T-C is Benign according to our data. Variant chr6-6222016-T-C is described in ClinVar as Benign. ClinVar VariationId is 255182.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.0133 (2023/152308) while in subpopulation AFR AF = 0.0262 (1089/41558). AF 95% confidence interval is 0.0249. There are 33 homozygotes in GnomAd4. There are 966 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 33 AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000129.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
F13A1
NM_000129.4
MANE Select
c.1112+17A>G
intron
N/ANP_000120.2

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
F13A1
ENST00000264870.8
TSL:1 MANE Select
c.1112+17A>G
intron
N/AENSP00000264870.3
F13A1
ENST00000950947.1
c.1112+17A>G
intron
N/AENSP00000621006.1
F13A1
ENST00000878383.1
c.923+17A>G
intron
N/AENSP00000548442.1

Frequencies

GnomAD3 genomes
AF:
0.0132
AC:
2009
AN:
152190
Hom.:
33
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0260
Gnomad AMI
AF:
0.00219
Gnomad AMR
AF:
0.0111
Gnomad ASJ
AF:
0.0236
Gnomad EAS
AF:
0.000192
Gnomad SAS
AF:
0.00704
Gnomad FIN
AF:
0.000941
Gnomad MID
AF:
0.0506
Gnomad NFE
AF:
0.00858
Gnomad OTH
AF:
0.0163
GnomAD2 exomes
AF:
0.00892
AC:
2233
AN:
250316
AF XY:
0.00901
show subpopulations
Gnomad AFR exome
AF:
0.0265
Gnomad AMR exome
AF:
0.00750
Gnomad ASJ exome
AF:
0.0218
Gnomad EAS exome
AF:
0.000109
Gnomad FIN exome
AF:
0.000993
Gnomad NFE exome
AF:
0.00867
Gnomad OTH exome
AF:
0.0106
GnomAD4 exome
AF:
0.00774
AC:
11308
AN:
1460632
Hom.:
81
Cov.:
31
AF XY:
0.00790
AC XY:
5744
AN XY:
726684
show subpopulations
African (AFR)
AF:
0.0252
AC:
842
AN:
33464
American (AMR)
AF:
0.00807
AC:
361
AN:
44710
Ashkenazi Jewish (ASJ)
AF:
0.0202
AC:
528
AN:
26128
East Asian (EAS)
AF:
0.0000756
AC:
3
AN:
39678
South Asian (SAS)
AF:
0.00835
AC:
720
AN:
86232
European-Finnish (FIN)
AF:
0.00134
AC:
71
AN:
52874
Middle Eastern (MID)
AF:
0.0516
AC:
297
AN:
5758
European-Non Finnish (NFE)
AF:
0.00702
AC:
7797
AN:
1111434
Other (OTH)
AF:
0.0114
AC:
689
AN:
60354
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.481
Heterozygous variant carriers
0
554
1108
1662
2216
2770
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
292
584
876
1168
1460
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0133
AC:
2023
AN:
152308
Hom.:
33
Cov.:
32
AF XY:
0.0130
AC XY:
966
AN XY:
74484
show subpopulations
African (AFR)
AF:
0.0262
AC:
1089
AN:
41558
American (AMR)
AF:
0.0111
AC:
170
AN:
15310
Ashkenazi Jewish (ASJ)
AF:
0.0236
AC:
82
AN:
3468
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5186
South Asian (SAS)
AF:
0.00725
AC:
35
AN:
4826
European-Finnish (FIN)
AF:
0.000941
AC:
10
AN:
10622
Middle Eastern (MID)
AF:
0.0544
AC:
16
AN:
294
European-Non Finnish (NFE)
AF:
0.00859
AC:
584
AN:
68022
Other (OTH)
AF:
0.0161
AC:
34
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
105
209
314
418
523
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
24
48
72
96
120
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0131
Hom.:
4
Bravo
AF:
0.0140
Asia WGS
AF:
0.00722
AC:
25
AN:
3478

ClinVar

ClinVar submissions as Germline
Significance:Benign
Revision:criteria provided, single submitter
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
not specified (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.82
CADD
Benign
5.4
DANN
Benign
0.62
PhyloP100
0.55
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3024480; hg19: chr6-6222249; API